Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2021-05-07 | 2021-06-07 | 138971 |
| APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2024-01-05 | 2024-02-02 | 215221 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2024-02-02 | 2024-03-01 | 218388 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-05-13 | 2020-05-25 | 114955 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-05-20 | 2020-05-25 | 115404 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2018-08-27 | 2018-11-30 | 59305 |
| APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2018-10-19 | 2019-02-06 | 64956 |
| APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2017-05-24 | 2017-06-21 | 11087 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-06-06 | 2017-08-28 | 12074 |
| APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2017-06-21 | 2017-11-21 | 13475 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-06-28 | 2017-11-20 | 14204 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2017-06-28 | 2017-11-09 | 14207 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2017-06-28 | 2018-03-29 | 14210 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2017-06-28 | 2017-11-09 | 14213 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2019-01-03 | 2019-01-17 | 71148 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2019-02-06 | 2019-03-07 | 74932 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2024-08-22 | 2024-11-01 | 235689 |
| APO-RANITIDINE | 15MG | SOLUTION | Resolved | 2019-02-13 | 2019-04-05 | 75626 |
| APO-RANITIDINE | 15MG | SOLUTION | Resolved | 2019-05-22 | 2019-05-31 | 84541 |
| APO-RANITIDINE | 15MG | SOLUTION | Actual shortage | 2019-09-18 | 2019-09-18 | 94180 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP OPH SOLN 0.25% | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |